Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s share price shot up 5.4% during mid-day trading on Monday . The stock traded as high as $101.36 and last traded at $100.45. 691,640 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,470,370 shares. The stock had previously closed at $95.33.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 1.8 %
The firm’s fifty day moving average price is $101.49 and its 200-day moving average price is $119.70.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Hedge funds have recently modified their holdings of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the third quarter valued at approximately $43,000. Dunhill Financial LLC acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at $46,000. Spire Wealth Management acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at $68,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth $279,000. Finally, SG Americas Securities LLC grew its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 49.3% in the 3rd quarter. SG Americas Securities LLC now owns 3,199 shares of the company’s stock worth $412,000 after acquiring an additional 1,057 shares during the last quarter.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Recommended Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Calculate Stock Profit
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.